Tularemia: Pathogenesis and Host Response
Tularemia: Pathogenesis and Host Response
批准号:
7662480
负责人:
Karl E Klose
金额:
$116.73万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-08 至 2012-06-30
中文摘要
描述(由申请人提供):土拉热弗朗西斯菌可导致人类严重疾病和死亡。F.土拉菌病被认为是最有可能的生物武器之一,因为它易于通过雾化传播,而且与吸入性土拉菌病相关的发病率和死亡率很高。目前还没有许可用于一般用途的兔热病疫苗,因此人类群体面临着非法使用F.土拉热。关于F的知之甚少。土拉热菌的致病机理和宿主反应,从而为土拉热菌的基础研究奠定了基础。土拉菌生物学对于未来开发抗土拉菌病的治疗剂和疫苗至关重要。我们已经从德克萨斯大学圣安东尼奥和德克萨斯大学圣安东尼奥健康科学中心的研究人员那里收集了一组集中于弗朗西斯菌发病机制和免疫的综合研究项目。各个项目被设计成与其他项目高度整合,并最终导致协同作用,这将推动我们对这种潜在生物武器的了解,从而可以开发新的抗菌策略。事实上,对F.土拉热亚种土拉热病(A型),最有可能的生物武器形式的土拉热病,因此,本方案项目几乎完全侧重于这种形式的土拉热病。我们的综合细菌学和免疫学研究方法涉及四个研究项目和三个支持核心。这些项目旨在1。鉴定F. tularensis,2.详细介绍了吸入性兔热病的免疫学特点,3.表征Toll样受体在宿主应答中的作用,和4.鉴定T细胞表位和表征T细胞介导的对F.土拉热。这些项目将得到一个行政核心、一个基因组学核心和一个免疫显微镜核心的支持。研究人员的合作互动将最终导致我们对F.土拉热亚种土拉菌气溶胶感染,并促进新的治疗和疫苗的开发,以打击武器化的土拉菌。
英文摘要
DESCRIPTION (provided by applicant): Francisella tularensis can cause serious illness and death in humans. F. tularensis is considered to be one of the most likely bioweapons due to ease of dissemination through aerosolization, and the high morbidity and mortality associated with inhalation tularemia. There is currently no tularemia vaccine licensed for general use, and thus human populations are at significant risk from the illicit use of F. tularensis. Very little is known about F. tularensis pathogenesis and host response, and thus fundamental research into F. tularensis biology is critical for the future development of therapeutics and vaccines against tularemia. We have assembled a group of integrated research projects focused on Francisella pathogenesis and immunity from researchers at the University of Texas San Antonio and the University of Texas Health Science Center in San Antonio. The individual projects are designed to be highly integrated with the other projects, and ultimately lead to a synergy that will propel our knowledge of this potential bioweapon such that new antimicrobial strategies can be developed. Virtually nothing is known about aerosol infections of F. tularensis subsp. tularensis (Type A), the most likely bioweapon form of tularemia, and thus this program project focuses almost exclusively on this form of tularemia. Our integrated bacteriological and immunological research approach involves four research projects and three support cores. These projects are designed to 1. identify essential and virulence factors of F. tularensis, 2. detail the immunology of inhalation tularemia in situ, 3. characterize the role of Toll-like receptors in host response, and 4. identify T cell epitopes and characterize T cell mediated responses to F. tularensis. These projects will be supported by an administrative core, a genomics core, and an immunomicroscopy core. The collaborative interactions of the investigators will ultimately lead to a dramatic increase in our understanding of pathogen-host interactions during F. tularensis subsp. tularensis aerosol infections, and facilitate the development of novel therapeutics and vaccines to combat weaponized tularemia.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge.
存在传染性细胞外土拉弗朗西斯菌亚种。
DOI:
10.1007/s10096-007-0434-x
发表时间:
2008
期刊:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
影响因子:
--
作者:
[Yu,J-J, Raulie,EK, Murthy,AK, Guentzel,MN, Klose,KE, Arulanandam,BP]
通讯作者:
Arulanandam,BP
DOI:
10.1371/journal.ppat.1004439
发表时间:
2014-10
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Chu P, Cunningham AL, Yu JJ, Nguyen JQ, Barker JR, Lyons CR, Wilder J, Valderas M, Sherwood RL, Arulanandam BP, Klose KE]
通讯作者:
Klose KE
Francisella DnaK inhibits tissue-nonspecific alkaline phosphatase.
Francisella DnaK 抑制组织非特异性碱性磷酸酶。
DOI:
10.1074/jbc.m112.404400
发表时间:
2012
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Arulanandam,BernardP, Chetty,SenthilnathLakshmana, Yu,Jieh-Juen, Leonard,Sean, Klose,Karl, Seshu,Janakiram, Cap,Andrew, Valdes,JamesJ, Chambers,JamesP]
通讯作者:
Chambers,JamesP
DOI:
10.3389/fcimb.2011.00020
发表时间:
2011
期刊:
Frontiers in cellular and infection microbiology
影响因子:
5.7
作者:
[Chambers JP, Yu JJ, Jupelli M, Weintraub ST, Lopez-Ribot JL, Valdes JJ, Arulanandam BP]
通讯作者:
Arulanandam BP
Cyclic di-GMP stimulates biofilm formation and inhibits virulence of Francisella novicida.
环状二-GMP 刺激生物膜形成并抑制新杀弗朗西斯菌的毒力。
DOI:
10.1128/iai.00702-12
发表时间:
2012
期刊:
Infection and immunity
影响因子:
3.1
作者:
[Zogaj,Xhavit, Wyatt,GeoffC, Klose,KarlE]
通讯作者:
Klose,KarlE
共 11 条
10th International Conference on Tularemia
-
批准号:10722927
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2023
-
负责人:Karl E Klose
-
依托单位:
Development of Genetic techniques in Chlamydia
-
批准号:8383379
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2012
-
负责人:Karl E Klose
-
依托单位:
Development of Genetic techniques in Chlamydia
-
批准号:8470126
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2012
-
负责人:Karl E Klose
-
依托单位:
F. tularensis Virulence Protein Structure and Function
-
批准号:7314377
-
项目类别:
-
资助金额:$19.01万
-
财政年份:2007
-
负责人:Karl E Klose
-
依托单位:
F. tularensis Virulence Protein Structure and Function
-
批准号:7433908
-
项目类别:
-
资助金额:$21.1万
-
财政年份:2007
-
负责人:Karl E Klose
-
依托单位:
Administrative
-
批准号:6912416
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2005
-
负责人:Karl E Klose
-
依托单位:
Tularemia: Pathogenesis and Host Response
-
批准号:7255387
-
项目类别:
-
资助金额:$118.16万
-
财政年份:2005
-
负责人:Karl E Klose
-
依托单位:
Tularemia: Pathogenesis and Host Response
-
批准号:6910404
-
项目类别:
-
资助金额:$138.43万
-
财政年份:2005
-
负责人:Karl E Klose
-
依托单位:
Characterization of F. tularensis Virulence Genes
-
批准号:6912409
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2005
-
负责人:Karl E Klose
-
依托单位:
Tularemia: Pathogenesis and Host Response
-
批准号:7092526
-
项目类别:
-
资助金额:$121.14万
-
财政年份:2005
-
负责人:Karl E Klose
-
依托单位:
Environmental Modulation of ToxT-dependent Transcription
-
批准号:6937448
-
项目类别:
-
资助金额:$15.72万
-
财政年份:2002
-
负责人:Karl E Klose
-
依托单位:
Environmental Modulation of ToxT-dependent Transcription
-
批准号:6986713
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2002
-
负责人:Karl E Klose
-
依托单位:
Environmental Modulation of ToxT-dependent Transcription
-
批准号:7148678
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2002
-
负责人:Karl E Klose
-
依托单位:
Environmental Modulation of ToxT-dependent Transcription
-
批准号:6574703
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2002
-
负责人:Karl E Klose
-
依托单位:
Environmental Modulation of ToxT-dependent Transcription
-
批准号:6828204
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2002
-
负责人:Karl E Klose
-
依托单位:
Environmental Modulation of ToxT-dependent Transcription
-
批准号:6685272
-
项目类别:
-
资助金额:$9.83万
-
财政年份:2002
-
负责人:Karl E Klose
-
依托单位:
An Oral Vaccine Against Multiple Biowarfare Agents
-
批准号:6532894
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2001
-
负责人:Karl E Klose
-
依托单位:
An Oral Vaccine Against Multiple Biowarfare Agents
-
批准号:6696090
-
项目类别:
-
资助金额:$3.08万
-
财政年份:2001
-
负责人:Karl E Klose
-
依托单位:
An Oral Vaccine Against Multiple Biowarfare Agents
-
批准号:6414431
-
项目类别:
-
资助金额:$35.24万
-
财政年份:2001
-
负责人:Karl E Klose
-
依托单位:
An Oral Vaccine Against Multiple Biowarfare Agents
-
批准号:6752742
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2001
-
负责人:Karl E Klose
-
依托单位:
海外基金